GILEAD SCIENCES, INC. Cost of Goods Sold (Deprecated 2018-01-31)
GILEAD SCIENCES, INC. (GILD) reported Cost of Goods Sold (Deprecated 2018-01-31) of $1.00 billion for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-05-09
- GILEAD SCIENCES, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $1.00B, a 4.60% increase year-over-year.
- GILEAD SCIENCES, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $1.26B, a 16.84% increase year-over-year.
- GILEAD SCIENCES, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $1.03B, a 8.59% decline year-over-year.
- GILEAD SCIENCES, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $1.13B, a 30.32% increase year-over-year.
- GILEAD SCIENCES, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $4.37B, a 2.58% increase from fiscal 2016.
- GILEAD SCIENCES, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $4.26B, a 6.37% increase from fiscal 2015.
- GILEAD SCIENCES, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $4.01B, a 5.76% increase from fiscal 2014.
- GILEAD SCIENCES, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $3.79B, a 32.49% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $1.00B 10-Q · filed 2018-05-09 | $2.26B derived: sum of 2 quarters · filed 2018-05-09 | $3.29B derived: sum of 3 quarters · filed 2018-05-09 | $4.42B derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-12-31 | $1.26B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.29B derived: sum of 2 quarters · filed 2018-02-27 | $3.41B derived: sum of 3 quarters · filed 2018-02-27 | $4.37B 10-K · filed 2018-02-27 | ||||
| 2017-09-30 | $1.03B 10-Q · filed 2017-11-07 | $2.16B derived: sum of 2 quarters · filed 2017-11-07 | $3.12B 10-Q · filed 2017-11-07 | $4.19B derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-06-30 | $1.13B 10-Q · filed 2017-08-07 | $2.08B 10-Q · filed 2017-08-07 | $3.16B derived: sum of 3 quarters · filed 2018-05-09 | $4.29B derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-03-31 | $957.00M 10-Q · filed 2018-05-09 | $2.03B derived: sum of 2 quarters · filed 2018-05-09 | $3.16B derived: sum of 3 quarters · filed 2018-05-09 | $4.03B derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2016-12-31 | $1.07B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.20B derived: sum of 2 quarters · filed 2018-02-27 | $3.07B derived: sum of 3 quarters · filed 2018-02-27 | $4.26B 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | $1.13B 10-Q · filed 2017-11-07 | $1.99B derived: sum of 2 quarters · filed 2017-11-07 | $3.19B 10-Q · filed 2017-11-07 | $4.25B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $864.00M 10-Q · filed 2017-08-07 | $2.06B 10-Q · filed 2017-08-07 | $3.12B derived: sum of 3 quarters · filed 2018-02-27 | $4.18B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $1.19B 10-Q · filed 2017-05-10 | $2.25B derived: sum of 2 quarters · filed 2018-02-27 | $3.32B derived: sum of 3 quarters · filed 2018-02-27 | $4.32B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $1.06B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.13B derived: sum of 2 quarters · filed 2018-02-27 | $3.12B derived: sum of 3 quarters · filed 2018-02-27 | $4.01B 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $1.06B 10-Q · filed 2016-11-07 | $2.06B derived: sum of 2 quarters · filed 2016-11-07 | $2.94B 10-Q · filed 2016-11-07 | $4.01B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $998.00M 10-Q · filed 2016-08-05 | $1.88B 10-Q · filed 2016-08-05 | $2.94B derived: sum of 3 quarters · filed 2017-02-27 | $3.93B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $882.00M 10-Q · filed 2016-05-06 | $1.95B derived: sum of 2 quarters · filed 2017-02-27 | $2.93B derived: sum of 3 quarters · filed 2017-02-27 | $3.86B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $1.06B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $2.05B derived: sum of 2 quarters · filed 2017-02-27 | $2.98B derived: sum of 3 quarters · filed 2017-02-27 | $3.79B 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $987.00M 10-Q · filed 2015-11-04 | $987.31M 10-Q · filed 2014-11-05 | $1.91B derived: sum of 2 quarters · filed 2015-11-04 | $2.73B 10-Q · filed 2015-11-04 | $2.73B 10-Q · filed 2014-11-05 | $3.58B derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | $925.00M 10-Q · filed 2015-08-05 | $924.71M 10-Q · filed 2014-08-04 | $1.74B 10-Q · filed 2015-08-05 | $1.74B 10-Q · filed 2014-08-04 | $2.60B derived: sum of 3 quarters · filed 2016-02-24 | $3.28B derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | $813.00M 10-Q · filed 2015-05-08 | $813.21M 10-Q · filed 2014-05-07 | $1.67B derived: sum of 2 quarters · filed 2016-02-24 | $2.35B derived: sum of 3 quarters · filed 2016-02-24 | $3.04B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $858.02M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $1.54B derived: sum of 2 quarters · filed 2016-02-24 | $2.22B derived: sum of 3 quarters · filed 2016-02-24 | $2.86B 10-K · filed 2016-02-24 | $2.86B 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $681.87M 10-Q · filed 2014-11-05 | $1.37B derived: sum of 2 quarters · filed 2014-11-05 | $2.00B 10-Q · filed 2014-11-05 | $2.68B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $684.66M 10-Q · filed 2014-08-04 | $1.32B 10-Q · filed 2014-08-04 | $1.99B derived: sum of 3 quarters · filed 2015-02-25 | $2.59B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $634.45M 10-Q · filed 2014-05-07 | $1.31B derived: sum of 2 quarters · filed 2015-02-25 | $1.91B derived: sum of 3 quarters · filed 2015-02-25 | $2.52B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $675.46M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $1.27B derived: sum of 2 quarters · filed 2015-02-25 | $1.89B derived: sum of 3 quarters · filed 2015-02-25 | $2.47B 10-K · filed 2015-02-25 | $2.47B 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $597.27M 10-Q · filed 2013-10-31 | $1.21B derived: sum of 2 quarters · filed 2013-10-31 | $1.80B 10-Q · filed 2013-10-31 | $2.38B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $617.35M 10-Q · filed 2013-08-01 | $1.20B 10-Q · filed 2013-08-01 | $1.78B derived: sum of 3 quarters · filed 2014-02-25 | $2.31B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $580.93M 10-Q · filed 2013-05-08 | $1.17B derived: sum of 2 quarters · filed 2014-02-25 | $1.70B derived: sum of 3 quarters · filed 2014-02-25 | $2.23B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $584.45M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $1.12B derived: sum of 2 quarters · filed 2014-02-25 | $1.65B derived: sum of 3 quarters · filed 2014-02-25 | $2.12B 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $531.99M 10-Q · filed 2012-11-06 | $1.07B derived: sum of 2 quarters · filed 2012-11-06 | $1.54B 10-Q · filed 2012-11-06 | $2.04B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $533.86M 10-Q · filed 2012-08-01 | $1.01B 10-Q · filed 2012-08-01 | $1.50B derived: sum of 3 quarters · filed 2013-02-27 | $1.98B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $474.11M 10-Q · filed 2012-05-04 | $970.45M derived: sum of 2 quarters · filed 2013-02-27 | $1.45B derived: sum of 3 quarters · filed 2013-02-27 | $1.90B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $496.34M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $973.92M derived: sum of 2 quarters · filed 2013-02-27 | $1.43B derived: sum of 3 quarters · filed 2013-02-27 | $1.87B 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $477.58M 10-Q · filed 2011-11-04 | $933.11M derived: sum of 2 quarters · filed 2011-11-04 | $1.37B 10-Q · filed 2011-11-04 | $1.85B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-06-30 | $455.52M 10-Q · filed 2011-08-05 | $895.96M 10-Q · filed 2011-08-05 | $1.37B derived: sum of 3 quarters · filed 2012-02-23 | $1.78B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-03-31 | $440.43M 10-Q · filed 2011-05-09 | $913.83M derived: sum of 2 quarters · filed 2012-02-23 | $1.32B derived: sum of 3 quarters · filed 2012-02-23 | $1.71B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2009-12-31 | $473.40M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $883.10M derived: sum of 2 quarters · filed 2012-02-23 | $1.27B derived: sum of 3 quarters · filed 2012-02-23 | $1.60B 10-K · filed 2012-02-23 | ||||
| 2009-09-30 | $409.70M 10-Q · filed 2010-11-08 | $792.75M derived: sum of 2 quarters · filed 2010-11-08 | $1.12B 10-Q · filed 2010-11-08 | $1.44B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-06-30 | $383.05M 10-Q · filed 2010-08-09 | $712.46M 10-Q · filed 2010-08-09 | $1.03B derived: sum of 3 quarters · filed 2011-02-28 | $1.33B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-03-31 | $329.41M 10-Q · filed 2010-05-10 | $650.95M derived: sum of 2 quarters · filed 2011-02-28 | $951.13M derived: sum of 3 quarters · filed 2011-02-28 | $1.22B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2008-12-31 | $321.53M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $621.71M derived: sum of 2 quarters · filed 2011-02-28 | $887.40M derived: sum of 3 quarters · filed 2011-02-28 | $1.13B 10-K · filed 2011-02-28 | ||||
| 2008-09-30 | $300.18M 10-Q · filed 2009-11-05 | $565.87M derived: sum of 2 quarters · filed 2009-11-05 | $805.72M 10-Q · filed 2009-11-05 | |||||
| 2008-06-30 | $265.68M 10-Q · filed 2009-08-05 | $505.53M 10-Q · filed 2009-08-05 | ||||||
| 2007-12-31 | $768.77M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |